摘要
目的:探讨胰腺衍生因子(PANDER)在前列腺癌(PCa)中的表达及其意义。方法:应用免疫组织化学SP法检测48例PCa组织和24例BPH组织标本的PANDER表达。结果:PANDER蛋白在前列腺(癌)上皮细胞中表达,在PCa组织中的阳性表达率为31.25%,在BPH组织中的阳性表达率为83.33%。PCa组织中PANDER阳性表达明显低于BPH组织,差异有统计学意义(P<0.001)。PANDER在PCa的Gleason分级为高分化组、中分化组和低分化组中的阳性表达率分别为57.14%、38.89%和17.39%(P<0.05)。结论:PANDER在PCa发生、发展、浸润的过程中可能发挥了一定作用。
Objective: To investigate the expression of Pancreatic-Derived Factor(PANDER) protein and its significance in prostate cancer. Methods: The expressions of PANDER protein was detected in 48 cases of prostate cancer and 24 cases of benign prostate hyperplasia(BPH)by immunohistochemistry. Results: The PANDER protein was expressed in prostate endothelial cell. The positive expression rate of PANDER was 31.25% in prostate cancer, significantly lower than 83.33% in BPH (P〈0. 001). Statistically significant difference was found. The positive expression rate of PANDER among different Gleason grades, 57.14% in well differentiated, 38.89% in moderately differentiated, and 17.39% in lowly differentiated prostate cancer (P〈0.05). Conclusions: The PANDER protein may play a certain role in the development, progression and infihration of prostate cancer.
出处
《临床泌尿外科杂志》
2012年第9期654-656,共3页
Journal of Clinical Urology
基金
海南省自然科学基金资助项目(编号808164)